The Invesco India Midcap Fund, managed by Aditya Khemani, has outperformed its peers and benchmarks with a three-year CAGR of 24.04%, showcasing resilience and growth amid India’s steady market recovery in 2026.
Indian markets have remained comparatively steady through 2026, supported by firmer earnings, easing inflation and a better mood among foreign investors, even as overseas tensions and trade shifts have periodically unsettled sentiment. Within that backdrop, mid-cap and small-cap shares have regained momentum, while large companies have continued to do much of the heavy lifting in the broader market.
That setting has helped put the Invesco India Midcap Fund back in focus. The open-ended equity scheme, launched in April 2007, is built to invest mainly in mid-sized companies with durable earnings growth and reasonable long-term valuations. As of July 31, 2026, the fund had delivered a 3-year compound annual growth rate of 24.04%, ahead of the BSE 150 MidCap TRI’s 17.94% return over the same period, according to figures cited by the fund house. Over five years, the fund posted a CAGR of 19.17%; over 10 years, 18.21%; and since inception, 16.73%.
Moneycontrol reported that the fund also led its peer group on a three-year CAGR basis, with a return of 24.9% as of July 21, 2026, and said it beat the benchmark’s 8.3% over that stretch. The same report said it also topped the category on one-year returns, gaining 9.16% against a benchmark decline of 2.5%. The fund’s assets under management stood at ₹14,721 crore at the end of July, according to the report.
The fund has been managed by Aditya Khemani since November 2023. Invesco Mutual Fund and ICICI Direct both say Khemani has extensive industry experience and that he continued overseeing the mid-cap strategy after a broader fund-management reshuffle at the firm in January 2026. Recent fund data from third-party trackers also show the portfolio holding sizeable positions in names such as Prestige Estates Projects, Federal Bank, Max Healthcare Institute, Meesho and Global Health, underlining the scheme’s focus on growth-oriented businesses in sectors linked to India’s domestic demand story.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
